Cargando…

Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study

PURPOSE: To study topical timolol (0.5%) as a first-line treatment in ophthalmic pyogenic granuloma (PG) in terms of safety and efficacy. METHODS: This was a prospective, interventional, single-arm study conducted at a tertiary eye care hospital in central India. Only new cases of PG were counseled...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jaiswal, Hrishabh, Patidar, Narendra, Shah, Chintan, Singh, Rukmendra, Jain, Elesh, Piyush, Parimal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8186631/ https://www.ncbi.nlm.nih.gov/pubmed/33913850 http://dx.doi.org/10.4103/ijo.IJO_2404_20

Ejemplares similares

Topical timolol for the treatment of conjunctival pyogenic granulomas: Outcomes and effect on intraocular pressure
por: Nair, Akshay Gopinathan, et al.
Publicado: (2020)

Oral propranolol and topical timolol in the treatment of post‐burn pyogenic granuloma: Two cases and a review of the literature
por: Ebrahimi, Zahra, et al.
Publicado: (2022)

Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial
por: Goldberg, Ivan, et al.
Publicado: (2014)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

A study of the safety and efficacy of travoprost 0.004%/timolol 0.5% ophthalmic solution compared to latanoprost 0.005% and timolol 0.5% dosed concomitantly in patients with open-angle glaucoma or ocular hypertension
por: Rhee, Douglas J, et al.
Publicado: (2008)

Abstract: Topical 0.5% Timolol for Chronic Refractory Wounds. an Observational Prospective Study
por: Vestita, Michelangelo, et al.
Publicado: (2017)

Topical Application of 0.5% Timolol Maleate Hydrogel for the Treatment of Superficial Infantile Hemangioma
por: Wu, Hai Wei, et al.
Publicado: (2017)

23-Year-old male with multiple giant facial pyogenic granulomas being treated with combined topical timolol and steroid: A case report
por: Kheder, Kheder, et al.
Publicado: (2022)

Fixed combination of topical brimonidine 0.2% and timolol 0.5% for glaucoma and uncontrolled intraocular pressure
por: Lee, Anne J, et al.
Publicado: (2008)

Effects of 0.5% Timolol Maleate Ophthalmic Solution on Heart Rate and Selected Echocardiographic Indices in Apparently Healthy Cats
por: Gunther‐Harrington, C.T., et al.
Publicado: (2016)

Topical brimonidine for pyogenic granuloma after paronychia surgery
por: Chen, Yusha, et al.
Publicado: (2020)

Complicated Infantile Hemangioma Successfully Treated with Topical Timolol 0.5% Solution: A Case Report
por: Borkar, Nitin, et al.
Publicado: (2021)

Efficacy and safety of fixed-combination travoprost 0.004%/timolol 0.5% in patients transitioning from bimatoprost 0.03%/timolol 0.5% combination therapy
por: Schnober, Dietmar, et al.
Publicado: (2015)

Safety and efficacy of switching from dorzolamide 1.0%/timolol maleate 0.5% eye drops to brinzolamide 1.0%/timolol maleate 0.5% eye drops
por: Inoue, Kenji, et al.
Publicado: (2015)

Infantile Hemangiomas with Minimal and Arrested Growth: Clinical Features and Treatment Outcomes with 0.5% Topical Timolol Maleate
por: Bae, Kyung-Nam, et al.
Publicado: (2021)

Association between Ophthalmic Timolol and Hospitalisation for Bradycardia
por: Pratt, Nicole L., et al.
Publicado: (2015)

Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin‐treated glaucoma patients
por: Aihara, Makoto, et al.
Publicado: (2017)

The effect of Timolol 0.5% on the correction of myopic regression after LASIK
por: Qi, Hong, et al.
Publicado: (2017)

A Comfort Survey of Timolol Hemihydrate 0.5% Solution Once or Twice Daily vs Timolol Maleate in Sorbate
por: Stewart, William C, et al.
Publicado: (2013)

Randomized Multicenter Clinical Trial Comparing 0.1% Brimonidine/0.5% Timolol Versus 1% Dorzolamide/0.5% Timolol as Adjuncts to Prostaglandin Analogues: Aibeta Crossover Study
por: Inatani, Masaru, et al.
Publicado: (2023)

Dermoscopy of Pyogenic Granuloma
por: Jha, Abhijeet K., et al.
Publicado: (2017)

Dermoscopy of pyogenic granuloma
por: Kissou, Amina, et al.
Publicado: (2017)

Pyogenic granuloma of the larynx
por: Hijazi, Leen Omar, et al.
Publicado: (2022)

Conjunctival Pyogenic Granuloma
por: Yoshida, Hana, et al.
Publicado: (2020)

Orbito-sinal foreign body with floor fracture: an unusual presentation
por: Patidar, Narendra, et al.
Publicado: (2020)

Safety of Fixed-Combination Bimatoprost 0.03%/Timolol 0.5% Ophthalmic Solution at 6 Months in Chinese Patients with Open-Angle Glaucoma or Ocular Hypertension
por: Sun, Xinghuai, et al.
Publicado: (2022)

Comparison of the latanoprost 0.005%/timolol 0.5% + brinzolamide 1% versus dorzolamide 1%/timolol 0.5% + latanoprost 0.005%: a 12-week, randomized open-label trial
por: Nakakura, Shunsuke, et al.
Publicado: (2012)

Pooled results of two randomized clinical trials comparing the efficacy and safety of travoprost 0.004%/timolol 0.5% in fixed combination versus concomitant travoprost 0.004% and timolol 0.5%
por: Gross, Ronald L, et al.
Publicado: (2007)

Comparison of timolol 0.5% + brimonidine 0.2% + dorzolamide 2% versus timolol 0.5% + brimonidine 0.2% in a Mexican population with primary open-angle glaucoma or ocular hypertension
por: Baiza-Durán, Leopoldo Martín, et al.
Publicado: (2012)

Efficiency, safety, and patient preference of switching from dorzolamide 1%/timolol 0.5% to brinzolamide 1%/timolol 0.5% while maintaining the prostaglandin F2α analog
por: Shimizu, Yoshie, et al.
Publicado: (2015)

Impact of online classes and home confinement on myopia progression in children during COVID-19 pandemic: Digital eye strain among kids (DESK) study 4
por: Mohan, Amit, et al.
Publicado: (2022)

Prospective Observational Post-marketing Study of Tafluprost 0.0015%/Timolol 0.5% Combination Ophthalmic Solution for Glaucoma and Ocular Hypertension: Short-Term Efficacy and Safety
por: Takagi, Yasutaka, et al.
Publicado: (2016)

Complete Resolution of a Refractory Pyogenic Granuloma Following Topical Salt Treatment
por: Bin Rubaian, Nouf Faihan
Publicado: (2021)

A Phase III Randomized Clinical Trial of a 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination, Preservative-Free Ophthalmic Solution vs. 0.5% Timolol + 0.2% Brimonidine + 2.0% Dorzolamide Fixed Combination in Patients with Controlled Primary Open-Angle Glaucoma
por: Gómez-Aguayo, Francisco, et al.
Publicado: (2018)

Sclerotherapy for the Treatment of Pyogenic Granuloma
por: Sacchidanand, S, et al.
Publicado: (2013)

Huge Pyogenic Granuloma of the Penis
por: Akbulut, Fatih, et al.
Publicado: (2015)

Capillary hemangioma or pyogenic granuloma
por: Trivedi, Shilpa
Publicado: (2016)

Pyogenic Granuloma in an Unusual Site
por: Gowda, Dinesh, et al.
Publicado: (2017)

Pyogenic Granuloma and Arteriovenous Malformation
por: Rodrigues, Gabriel, et al.
Publicado: (2019)

An Uncommon Presentation of Pyogenic Granuloma
por: Luna-Ceron, Eder, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2dv2okr8052ab8nnbl27ve6rv3